Association of ventilator type with hospital mortality in critically ill patients with SARS-CoV2 infection: a prospective study

F. Bruneel | M. Salvetti | B. Livarek | Y. le Tulzo | G. Troché | A. Ferré | J. Bédos | S. Merceron | M. Delord | B. Veber | S. Legriel | P. Squara | F. Tamion | C. Charbonnel | R. Convers-Domart | O. Picq | C. Flaujac | P. Jullien | M. Paul | S. Marque-Juillet | Marine Arrayago | F. Perier | G. Lacavé | A. Maurizot | J. Raphalen | F. Stéphan | A. Gros | M. Amara | Hugo Bellut | A. Roche | Lucie Sabau | Anaïs Codorniu | M. Terris | Amael Ouassou | Fabien Marquion | V. Laurent | C. Simon | Sofia Georges Passem Marlène Marine Alix Pauline Jean-Pi Abbad Abi Abdallah Ahmed Amara Arrayago Aub | S. Abbad | Georges Abi Abdallah | P. Ahmed | Alix Aubry | Pauline Bargain | Michael Benayoun | Hotman Benhamida | Laura Benchetrit | Johan Benhard | Emilie Boglietto | R. Bordier | Antoine Brizard | Amélie Cambriel | Steven Causeret | Paul Chinardet | Adrien Coeffic | Wandrille de Carrere | Cyril Dekeyser | Alix Delaroche | Chloé Descamps | Juliette Didier | Pascaline Dorges | Lucie Fanet | C. Fauquenot | L. Gouzien | Louis Grandière | Juliana Henao-Brasseur | Jean-Didier Heymann | Charles Hickel | Myriam Lamamri | Bénédicte Le Clec’h | Marc Lessert | Céline Metzger | Hervé Michon | Marie-Sophie Minin | Ghislane Nid-Bella | Marianne Offredo | Hanna Paktoris | Hélène Poirier | Ariane Roujansky | Thomas Quenesson | J. Rouaux | Marie Saleten | Florence Sarfati | Celia Teissedre | Jean-François Vax | Cécile Vernet | A. Wormser | J. Vax | J. Benhard | G. Lacave | M. Benayoun

[1]  M. Kuiper,et al.  Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study , 2020, The Lancet Respiratory Medicine.

[2]  P. Póvoa,et al.  Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review , 2020, Clinical Microbiology and Infection.

[3]  L. Brochard,et al.  Reliability and limits of transport-ventilators to safely ventilate severe patients in special surge situations. , 2020, medRxiv.

[4]  É. Azoulay,et al.  High-Flow Nasal Cannula in Critically III Patients with Severe COVID-19 , 2020, American Journal of Respiratory and Critical Care Medicine.

[5]  J. Fink,et al.  High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion , 2020, European Respiratory Journal.

[6]  Y. Yeh,et al.  COVID-19 ICU and mechanical ventilation patient characteristics and outcomes—A systematic review and meta-analysis , 2020, medRxiv.

[7]  Arthur S Slutsky,et al.  Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial , 2020, Trials.

[8]  R. Attou,et al.  Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure , 2020, Critical Care.

[9]  R. Busse,et al.  Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study , 2020, The Lancet Respiratory Medicine.

[10]  M. Antonelli,et al.  Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. , 2020, JAMA internal medicine.

[11]  Jennifer L. Bell,et al.  Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.

[12]  J. Douketis,et al.  Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[13]  David J Murphy,et al.  ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019 , 2020, Critical care medicine.

[14]  D. Brodie,et al.  Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, medRxiv.

[15]  J. Fink,et al.  High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion , 2020, European Respiratory Journal.

[16]  S. Merler,et al.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.

[17]  A. Shehata,et al.  The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control , 2020, Journal of clinical medicine.

[18]  Giuseppe Citerio,et al.  Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) , 2020, Intensive Care Medicine.

[19]  A. Falanga,et al.  ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[20]  Qiurong Ruan,et al.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.

[21]  Yazdan Yazdanpanah,et al.  Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists , 2020, Intensive Care Medicine.

[22]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[23]  Daniel Brodie,et al.  Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation. , 2020, JAMA.

[24]  Novel Coronavirus Pneumonia Emergency Response Epidemiol Team.  [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[25]  B. Cowling,et al.  Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[26]  J. González-Martín,et al.  Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. , 2020, The Lancet. Respiratory medicine.

[27]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[28]  Q. Pham,et al.  Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam , 2020, The New England journal of medicine.

[29]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[30]  中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组.  The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China./ 新型冠状病毒肺炎流行病学特征分析 , 2020 .

[31]  SEPSIS BULLETIN,et al.  Surviving Sepsis Campaign : Guidelines on the Management of Critically Ill Adults with Coronavirus Disease , 2020 .

[32]  Gavin D Perkins,et al.  Guidelines on the management of acute respiratory distress syndrome , 2019, BMJ Open Respiratory Research.

[33]  D. Brodie,et al.  Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome , 2018, The New England journal of medicine.

[34]  Daniel Brodie,et al.  Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment , 2018, JAMA.

[35]  Ognjen Gajic,et al.  An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome , 2017, American journal of respiratory and critical care medicine.

[36]  J. Henzen.  Publisher's note. , 2018, Public health.

[37]  N. Marjanovic,et al.  A Comprehensive Approach for the Ergonomic Evaluation of 13 Emergency and Transport Ventilators , 2016, Respiratory Care.

[38]  T. Similowski,et al.  Multifaceted bench comparative evaluation of latest intensive care unit ventilators. , 2015, British journal of anaesthesia.

[39]  L. Brochard,et al.  High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. , 2015, The New England journal of medicine.

[40]  Annie Roy,et al.  Bench-test comparison of 26 emergency and transport ventilators , 2014, Critical Care.

[41]  S. Jaber,et al.  Prone positioning in severe acute respiratory distress syndrome. , 2013, The New England journal of medicine.

[42]  C. Guérin,et al.  Delivery of tidal volume from four anaesthesia ventilators during volume-controlled ventilation: a bench study. , 2013, British journal of anaesthesia.

[43]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[44]  P. Austin,et al.  Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies , 2010, Pharmaceutical statistics.

[45]  L. Brochard,et al.  Bench test evaluation of volume delivered by modern ICU ventilators during volume-controlled ventilation , 2010, Intensive Care Medicine.

[46]  A. Thille,et al.  Évolution des ventilateurs de réanimation , 2008 .

[47]  J. Avorn,et al.  Variable selection for propensity score models. , 2006, American journal of epidemiology.

[48]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[49]  S. Jaber,et al.  [Performance studies of 6 new anesthesia ventilators: bench tests]. , 2000, Annales francaises d'anesthesie et de reanimation.

[50]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.

[51]  J SMITH,et al.  Intensive care unit. , 1962, Nursing times.